2015 Q4 Form 10-K Financial Statement

#000087504517000009 Filed on February 02, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $2.839B $2.778B $2.592B
YoY Change 7.52% 10.61% 7.02%
Cost Of Revenue $331.8M $310.0M $286.1M
YoY Change 11.6% 2.43% -1.98%
Gross Profit $2.508B $2.468B $2.306B
YoY Change 7.0% 11.73% 8.26%
Gross Profit Margin 88.31% 88.84% 88.96%
Selling, General & Admin $583.0M $477.8M $491.9M
YoY Change 1.64% -16.24% -14.69%
% of Gross Profit 23.25% 19.36% 21.34%
Research & Development $541.7M $519.9M $490.7M
YoY Change 8.32% 24.62% 9.71%
% of Gross Profit 21.6% 21.07% 21.28%
Depreciation & Amortization $156.3M $151.6M $144.6M
YoY Change -0.89% -13.57% -11.88%
% of Gross Profit 6.23% 6.14% 6.27%
Operating Expenses $1.246B $997.7M $982.6M
YoY Change 4.86% 1.02% -4.03%
Operating Profit $1.262B $1.372B $1.233B
YoY Change 9.21% 19.02% 24.72%
Interest Expense -$76.20M $15.60M $5.800M
YoY Change 902.63% 110.81% -18.31%
% of Operating Profit -6.04% 1.14% 0.47%
Other Income/Expense, Net -$6.200M -$15.40M -$10.90M
YoY Change 416.67% -5.46% -324.23%
Pretax Income $1.086B $1.356B $1.222B
YoY Change -5.66% 19.37% 23.01%
Income Tax $257.1M $330.1M $292.5M
% Of Pretax Income 23.68% 24.34% 23.93%
Net Earnings $831.6M $965.6M $927.3M
YoY Change -5.87% 12.69% 29.78%
Net Earnings / Revenue 29.29% 34.76% 35.78%
Basic Earnings Per Share $3.77 $4.16 $3.94
Diluted Earnings Per Share $3.77 $4.15 $3.93
COMMON SHARES
Basic Shares Outstanding 220.4M shares 232.2M shares 235.3M shares
Diluted Shares Outstanding 220.8M shares 232.6M shares 235.7M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.429B $5.843B $2.369B
YoY Change 85.85% 213.97% 50.6%
Cash & Equivalents $1.308B $4.089B $1.282B
Short-Term Investments $2.121B $1.753B $1.087B
Other Short-Term Assets $836.9M $861.9M $750.0M
YoY Change 170.14% 117.39% 116.28%
Inventory $893.4M $918.9M $865.7M
Prepaid Expenses
Receivables $1.227B $1.328B $1.311B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.700B $9.271B $5.619B
YoY Change 47.75% 112.05% 43.16%
LONG-TERM ASSETS
Property, Plant & Equipment $2.188B $2.028B $1.838B
YoY Change 23.89% 17.61% 4.64%
Goodwill $2.664B $2.409B $2.154B
YoY Change 51.34% 56.3% 57.85%
Intangibles $4.085B $4.181B $4.295B
YoY Change 1.4% 1.25% 1.07%
Long-Term Investments $3.868B $2.834B $2.853B
YoY Change 74.0% 46.92% 75.89%
Other Assets $1.108B $892.2M $751.6M
YoY Change 46.78% 57.77% 22.85%
Total Long-Term Assets $12.80B $11.46B $11.14B
YoY Change 30.93% 22.78% 23.88%
TOTAL ASSETS
Total Short-Term Assets $6.700B $9.271B $5.619B
Total Long-Term Assets $12.80B $11.46B $11.14B
Total Assets $19.50B $20.73B $16.76B
YoY Change 36.26% 51.26% 29.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $267.4M $251.2M $282.7M
YoY Change 16.67% 7.53% 25.68%
Accrued Expenses $1.101B $832.0M $823.0M
YoY Change 4.86% -1.77% 2.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $5.000M $3.000M
YoY Change 66.67% 66.67% 0.0%
Total Short-Term Liabilities $2.578B $2.634B $2.556B
YoY Change 16.21% 35.73% 33.35%
LONG-TERM LIABILITIES
Long-Term Debt $6.522B $6.529B $576.0M
YoY Change 1024.48% 1017.98% -1.71%
Other Long-Term Liabilities $905.8M $861.4M $915.7M
YoY Change 39.33% 30.86% 28.8%
Total Long-Term Liabilities $905.8M $861.4M $915.7M
YoY Change 39.33% 30.86% 28.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.578B $2.634B $2.556B
Total Long-Term Liabilities $905.8M $861.4M $915.7M
Total Liabilities $10.13B $10.16B $4.186B
YoY Change 189.37% 210.44% 24.86%
SHAREHOLDERS EQUITY
Retained Earnings $12.21B $12.00B $11.03B
YoY Change 31.5% 42.84% 46.27%
Common Stock $100.0K $124.0K $129.0K
YoY Change 0.0% -3.88% 0.78%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.612B $2.612B $2.612B
YoY Change 0.0% 25.27% 26.67%
Treasury Stock Shares 22.60M shares
Shareholders Equity $9.373B $10.57B $12.57B
YoY Change
Total Liabilities & Shareholders Equity $19.50B $20.73B $16.76B
YoY Change 36.26% 51.26% 29.74%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income $831.6M $965.6M $927.3M
YoY Change -5.87% 12.69% 29.78%
Depreciation, Depletion And Amortization $156.3M $151.6M $144.6M
YoY Change -0.89% -13.57% -11.88%
Cash From Operating Activities $1.040B $895.4M $1.047B
YoY Change 11.54% -2.05% 5.72%
INVESTING ACTIVITIES
Capital Expenditures -$186.1M -$229.2M -$129.9M
YoY Change 74.09% 266.13% 102.97%
Acquisitions
YoY Change
Other Investing Activities -$1.621B -$760.8M -$1.124B
YoY Change 497.42% 59.16% 98.46%
Cash From Investing Activities -$1.808B -$990.0M -$1.253B
YoY Change 377.8% 83.13% 98.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.998B 2.908B -3.600M
YoY Change 289.32% -8383.76% -98.88%
NET CHANGE
Cash From Operating Activities 1.040B 895.4M 1.047B
Cash From Investing Activities -1.808B -990.0M -1.253B
Cash From Financing Activities -1.998B 2.908B -3.600M
Net Change In Cash -2.766B 2.813B -209.6M
YoY Change -6812.38% 731.26% -650.13%
FREE CASH FLOW
Cash From Operating Activities $1.040B $895.4M $1.047B
Capital Expenditures -$186.1M -$229.2M -$129.9M
Free Cash Flow $1.227B $1.125B $1.177B
YoY Change 17.97% 15.14% 11.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 biib Accrued Expenses On Funding Commitment Related To Clinical Research
AccruedExpensesOnFundingCommitmentRelatedToClinicalResearch
21000000 USD
CY2014 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
16000000 USD
CY2015 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
32300000 USD
CY2016 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
16700000 USD
CY2015Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
185300000 USD
CY2016Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
277500000 USD
CY2015Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
184500000 USD
CY2016Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
276800000 USD
CY2015 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P16M
CY2016 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P12M
CY2014 biib Collaboration Profit Sharing
CollaborationProfitSharing
0 USD
CY2015 biib Collaboration Profit Sharing
CollaborationProfitSharing
0 USD
CY2016 biib Collaboration Profit Sharing
CollaborationProfitSharing
10200000 USD
CY2015Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
31200000 USD
CY2016Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
130900000 USD
CY2016 biib Compensation Expense Over Purchase Period
CompensationExpenseOverPurchasePeriod
The fair value of the look-back provision plus the 15% discount
CY2015Q4 biib Computer Software And Hardware
ComputerSoftwareAndHardware
647100000 USD
CY2016Q4 biib Computer Software And Hardware
ComputerSoftwareAndHardware
746800000 USD
CY2014 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
1651800000 USD
CY2015 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
2229400000 USD
CY2016 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
2668000000 USD
CY2016 biib Debt Instrument Make Whole Provision Redemption Price Percentage
DebtInstrumentMakeWholeProvisionRedemptionPricePercentage
1.01
CY2015Q4 biib Deferred Tax Liabilities Depreciation Amortization Other
DeferredTaxLiabilitiesDepreciationAmortizationOther
102700000 USD
CY2016Q4 biib Deferred Tax Liabilities Depreciation Amortization Other
DeferredTaxLiabilitiesDepreciationAmortizationOther
113500000 USD
CY2016 biib Discount Rate Recognized In Compensation Expense
DiscountRateRecognizedInCompensationExpense
0.15
CY2015Q4 biib Due From Unconsolidated Joint Business
DueFromUnconsolidatedJointBusiness
314500000 USD
CY2016Q4 biib Due From Unconsolidated Joint Business
DueFromUnconsolidatedJointBusiness
300600000 USD
CY2014 biib Effective Income Tax Rate Reconciliation Contingent Consideration
EffectiveIncomeTaxRateReconciliationContingentConsideration
-0.004
CY2015 biib Effective Income Tax Rate Reconciliation Contingent Consideration
EffectiveIncomeTaxRateReconciliationContingentConsideration
0.003
CY2016 biib Effective Income Tax Rate Reconciliation Contingent Consideration
EffectiveIncomeTaxRateReconciliationContingentConsideration
0.004
CY2014 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.018
CY2015 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.018
CY2016 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.019
CY2016 biib Estimated Useful Lives Of Leasehold Improvements
EstimatedUsefulLivesOfLeaseholdImprovements
Lesser of the useful life or the term of the respective lease
CY2015 biib Gain On Sale Of Rights
GainOnSaleOfRights
0 USD
CY2016 biib Gain On Sale Of Rights
GainOnSaleOfRights
0 USD
CY2014 biib Gain On Sale Of Rights
GainOnSaleOfRights
16800000 USD
CY2016 biib Interest In Subsidiary
InterestInSubsidiary
1.00
CY2015Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
933600000 USD
CY2016Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1039400000 USD
CY2015Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
29200000 USD
CY2016Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
47400000 USD
CY2016Q4 biib Net Minimum Lease Payments
NetMinimumLeasePayments
549500000 USD
CY2016Q4 biib Net Minimum Lease Payments Thereafter
NetMinimumLeasePaymentsThereafter
276500000 USD
CY2016Q4 biib Net Minimum Lease Payments With In Five Year
NetMinimumLeasePaymentsWithInFiveYear
48400000 USD
CY2016Q4 biib Net Minimum Lease Payments With In Four Year
NetMinimumLeasePaymentsWithInFourYear
50000000 USD
CY2016Q4 biib Net Minimum Lease Payments With In One Year
NetMinimumLeasePaymentsWithInOneYear
66400000 USD
CY2016Q4 biib Net Minimum Lease Payments With In Three Year
NetMinimumLeasePaymentsWithInThreeYear
53600000 USD
CY2016Q4 biib Net Minimum Lease Payments With In Two Year
NetMinimumLeasePaymentsWithInTwoYear
54600000 USD
CY2014 biib Noncontrollinginterestincreasedecreaseother
Noncontrollinginterestincreasedecreaseother
6700000 USD
CY2016 biib Number Of Share Based Compensation Plans Pursuant To Which Awards Are Currently Being Made
NumberOfShareBasedCompensationPlansPursuantToWhichAwardsAreCurrentlyBeingMade
3 Plan
CY2014 biib Other Income Expense Net
OtherIncomeExpenseNet
-8700000 USD
CY2015 biib Other Income Expense Net
OtherIncomeExpenseNet
-13800000 USD
CY2016 biib Other Income Expense Net
OtherIncomeExpenseNet
-17000000 USD
CY2015Q4 biib Overnightreverserepurchaseagreementspercentoftotalassets
Overnightreverserepurchaseagreementspercentoftotalassets
0.0071
CY2016 biib Payment Terms Of Accounts Receivable
PaymentTermsOfAccountsReceivable
30 to 90 days
CY2014 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
1237200000 USD
CY2015 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
1666600000 USD
CY2016 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
2099500000 USD
CY2014 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
341000000 USD
CY2015 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
351600000 USD
CY2016 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
609000000 USD
CY2016 biib Percentage Of Market Value Per Share Of Common Stock
PercentageOfMarketValuePerShareOfCommonStock
0.85
CY2016Q4 biib Potential Future Milestone Payments Commitment To Third Party Approximately
PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately
3100000000 USD
CY2016 biib Purchase Price Of Common Stock Under Espp
PurchasePriceOfCommonStockUnderEspp
85% of the lower of (i) the market value per share of the common stock on the participant's entry date into an offering period or (ii) the market value per share of the common stock on the purchase date
CY2014 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.12
CY2015 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.12
CY2016 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.11
CY2014 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1195400000 USD
CY2015Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
330600000 USD
CY2015Q2 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
337500000 USD
CY2015Q3 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
337200000 USD
CY2015Q4 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
333900000 USD
CY2015 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1339200000 USD
CY2016Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
329500000 USD
CY2016Q2 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
349200000 USD
CY2016Q3 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
317600000 USD
CY2016Q4 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
318200000 USD
CY2016 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1314500000 USD
CY2014 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
242400000 USD
CY2015 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
196300000 USD
CY2016 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
189800000 USD
CY2015Q4 biib Totaldeferredchargesandprepaidtaxes
Totaldeferredchargesandprepaidtaxes
697900000 USD
CY2016Q4 biib Totaldeferredchargesandprepaidtaxes
Totaldeferredchargesandprepaidtaxes
989800000 USD
CY2016 biib Weighted Average Period To Recognize Cost Of Nonvested Awards
WeightedAveragePeriodToRecognizeCostOfNonvestedAwards
P1Y11M
CY2014 biib Windfall Tax Benefits From Vesting Of Stock Awards Exercises Of Stock Options And Espp Participation
WindfallTaxBenefitsFromVestingOfStockAwardsExercisesOfStockOptionsAndEsppParticipation
96400000 USD
CY2015 biib Windfall Tax Benefits From Vesting Of Stock Awards Exercises Of Stock Options And Espp Participation
WindfallTaxBenefitsFromVestingOfStockAwardsExercisesOfStockOptionsAndEsppParticipation
78200000 USD
CY2016 biib Windfall Tax Benefits From Vesting Of Stock Awards Exercises Of Stock Options And Espp Participation
WindfallTaxBenefitsFromVestingOfStockAwardsExercisesOfStockOptionsAndEsppParticipation
12600000 USD
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000875045
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
215951945 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q2 dei Entity Public Float
EntityPublicFloat
52843669823 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
BIOGEN INC.
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
267400000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
279800000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1227000000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1441600000 USD
CY2015Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
167900000 USD
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
195800000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1330100000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1439300000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27700000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-59500000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-224000000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-319900000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
93000000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
69000000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
600000 USD
CY2014 us-gaap Advertising Expense
AdvertisingExpense
92900000 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
108600000 USD
CY2016 us-gaap Advertising Expense
AdvertisingExpense
106300000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
165000000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
183200000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169400000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
252400000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
207300000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
204400000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
489800000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
382600000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385600000 USD
CY2015Q4 us-gaap Assets
Assets
19504800000 USD
CY2016Q4 us-gaap Assets
Assets
22876800000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
6700300000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
8732200000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4891200000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5406300000 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
4880900000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5398000000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
300000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2900000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10600000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11200000 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4891200000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5406300000 USD
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2120500000 USD
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2568600000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2583900000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2559700000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2575900000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2552600000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2122000000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2569100000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2120500000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2568600000 USD
CY2014 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
700000 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1500000 USD
CY2016 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3300000 USD
CY2014 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
500000 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
3500000 USD
CY2016 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
4300000 USD
CY2015Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2760400000 USD
CY2016Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2829400000 USD
CY2015Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1035600000 USD
CY2016Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1107800000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
1200000000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
504700000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
580800000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
18700000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
2000000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
16700000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
600000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
18100000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
602600000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1204900000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1308000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326500000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
643200000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
148900000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1049800000 USD
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
909500000 USD
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2039600000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241200000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
238500000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218600000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215900000 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2903000000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3382500000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3606900000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6800000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-46200000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7100000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2909800000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3428700000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3599800000 USD
CY2015Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
441200000 USD
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
658600000 USD
CY2015Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
87900000 USD
CY2016Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
134000000 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1171000000 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1240400000 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1478700000 USD
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
5747700000 USD
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
5872800000 USD
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
6298400000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1159500000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1214100000 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1304300000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
73400000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
54500000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
52900000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1298100000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1307200000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1412300000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
65200000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
38600000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
55100000 USD
CY2015Q4 us-gaap Debt Current
DebtCurrent
4800000 USD
CY2016Q4 us-gaap Debt Current
DebtCurrent
4700000 USD
CY2015Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6645900000 USD
CY2016Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6808400000 USD
CY2016 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
less than 90 days
CY2016 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-280900000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-129600000 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-125600000 USD
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-6300000 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-14100000 USD
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-45600000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-308200000 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-145600000 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-175000000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-21000000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1900000 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3800000 USD
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
328300000 USD
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
459800000 USD
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
243900000 USD
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
250600000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
871700000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1071800000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24700000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
65900000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
35800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
49000000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
189300000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
201100000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
63800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
61500000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14100000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16100000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
542800000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
490100000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
440100000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
376600000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
124900000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
93100000 USD
CY2014 us-gaap Depreciation
Depreciation
198400000 USD
CY2015 us-gaap Depreciation
Depreciation
217900000 USD
CY2016 us-gaap Depreciation
Depreciation
309300000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
688100000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600400000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
682700000 USD
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.42
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.50
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.94
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.16
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.77
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.38
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.44
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.79
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.72
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.00
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
16.96
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.37
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.49
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.93
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.15
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.77
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
15.34
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.43
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.79
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.71
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.99
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
16.93
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40900000 USD
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-45800000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-31300000 USD
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.095
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.100
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
295200000 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.096
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.012
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.010
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.012
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.005
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.007
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.005
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.012
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.009
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.011
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.014
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
270800000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
282900000 USD
CY2014 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-10000000 USD
CY2015 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-11000000 USD
CY2016 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-14600000 USD
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
8500000 USD
CY2015 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
6300000 USD
CY2016 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
2200000 USD
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
189800000 USD
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
72200000 USD
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
55800000 USD
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
54000000 USD
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
13000000 USD
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
11900000 USD
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
4000000 USD
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
96400000 USD
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
78200000 USD
CY2016 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
12600000 USD
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
38900000 USD
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-30500000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-14800000 USD
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
274500000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
14500000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
53200000 USD
CY2015 us-gaap Fair Value Measurements Changes In Valuation Techniques
FairValueMeasurementsChangesInValuationTechniques
0
CY2016 us-gaap Fair Value Measurements Changes In Valuation Techniques
FairValueMeasurementsChangesInValuationTechniques
0
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3561200000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3934000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
334800000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
242800000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
259700000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4767300000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4933000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
312700000 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11600000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-32700000 USD
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9800000 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
72900000 USD
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
60600000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
126900000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter
55400000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears
16200000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears
15700000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
8900000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
15500000 USD
CY2016Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
15200000 USD
CY2014 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
15500000 USD
CY2015 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
23800000 USD
CY2016 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
29200000 USD
CY2014 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
11800000 USD
CY2015 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3800000 USD
CY2016 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
6000000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
1760200000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
2663800000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
3669300000 USD
CY2015 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
908100000 USD
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1026900000 USD
CY2016Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2015 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-4500000 USD
CY2016 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-21400000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
2242600000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
2305500000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
2467900000 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
2507500000 USD
CY2015 us-gaap Gross Profit
GrossProfit
9523400000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
2413800000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
2523900000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
2538900000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
2493500000 USD
CY2016 us-gaap Gross Profit
GrossProfit
9970100000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2557400000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3386700000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3655400000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1389200000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1380600000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1277600000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3946600000 USD
CY2014 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15100000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12500000 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
989900000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1161600000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1237300000 USD
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1163200000 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1674800000 USD
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1642200000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
512400000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241400000 USD
CY2014 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
40300000 USD
CY2015 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-429400000 USD
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-232600000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
244300000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
74200000 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
570100000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
185900000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
174400000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
165600000 USD
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
108700000 USD
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
127000000 USD
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-59100000 USD
CY2014 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
30700000 USD
CY2015 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
31100000 USD
CY2016 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-13900000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
68700000 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
83200000 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
69500000 USD
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7646300000 USD
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7742300000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4085100000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3808300000 USD
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
6400000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
10400000 USD
CY2016 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
12900000 USD
CY2014 us-gaap Interest Expense
InterestExpense
29500000 USD
CY2015 us-gaap Interest Expense
InterestExpense
95500000 USD
CY2016 us-gaap Interest Expense
InterestExpense
260000000 USD
CY2014 us-gaap Interest Paid Net
InterestPaidNet
41200000 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
39100000 USD
CY2016 us-gaap Interest Paid Net
InterestPaidNet
281200000 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143000000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
170300000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
893400000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
1001600000 USD
CY2015Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
40200000 USD
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
37800000 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
213000000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
170400000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
577600000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
698700000 USD
CY2014 us-gaap Inventory Write Down
InventoryWriteDown
50600000 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
41900000 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
48200000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
12200000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
22100000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
63400000 USD
CY2015Q4 us-gaap Land
Land
74700000 USD
CY2016Q4 us-gaap Land
Land
137800000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
62400000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
68600000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
68700000 USD
CY2015Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
166600000 USD
CY2016Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
123700000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
10129900000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
10748200000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19504800000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22876800000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2577700000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3419900000 USD
CY2016Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
47800000 USD
CY2015 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
CY2016Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 USD
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000000 USD
CY2015Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
454800000 USD
CY2016 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
1250000000 USD
CY2014 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2015 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2016 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
454800000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
6521500000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
6512700000 USD
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18100000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
16400000 USD
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1700000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1700000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
4500000000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3100000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1500000000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
553100000 USD
CY2016Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
6556200000 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1079600000 USD
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1105800000 USD
CY2016 us-gaap Maximum Remaining Maturity Of Foreign Currency Derivatives1
MaximumRemainingMaturityOfForeignCurrencyDerivatives1
P18M
CY2015Q4 us-gaap Minority Interest
MinorityInterest
2100000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-11500000 USD
CY2014 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9100000 USD
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
60000000 USD
CY2016 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1500000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-755900000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
986400000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-987800000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1543000000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4553600000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2484800000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2942100000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3716100000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4522400000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
2934800000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
822500000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
927300000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
965600000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
831600000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
3547000000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
970900000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1049800000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1032900000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
649200000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
3702800000 USD
CY2014 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6800000 USD
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
46200000 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7100000 USD
CY2016 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
7500000 USD
CY2015 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
10900000 USD
CY2016 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
600000 USD
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
1765700000 USD
CY2015Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2187600000 USD
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2501800000 USD
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
3972400000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
4891000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
5150400000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
676400000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
75300000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
64600000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
65700000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
69100000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
69800000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
331900000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
516200000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
685700000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
836900000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1093300000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1107600000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1335800000 USD
CY2016Q4 us-gaap Other Commitment
OtherCommitment
500000000 USD
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-6000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-400000 USD
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-10000000 USD
CY2014 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-19100000 USD
CY2015 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
6500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-92500000 USD
CY2014 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
95400000 USD
CY2015 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-61500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
47600000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-109200000 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-96400000 USD
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-138600000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31800000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-164500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
95800000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31800000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-164500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-95900000 USD
CY2014 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
12000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
6200000 USD
CY2016 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-5100000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
6400000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1300000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-600000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
6300000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
172300000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
4000000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
101700000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
110800000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
51600000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
400000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1700000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10600000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2096800000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2903500000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
905800000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
722500000 USD
CY2014 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
50300000 USD
CY2015 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-82200000 USD
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-91200000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25800000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123700000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-217400000 USD
CY2014 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
304500000 USD
CY2015Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
52000000 USD
CY2015Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
55600000 USD
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
49000000 USD
CY2015Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
79500000 USD
CY2015 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
236100000 USD
CY2016Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
87900000 USD
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
79000000 USD
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
98600000 USD
CY2016Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
50900000 USD
CY2016 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
316400000 USD
CY2014 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-12200000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
44500000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
22800000 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
886800000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000000000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000000000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 USD
CY2016 us-gaap Payments For Restructuring
PaymentsForRestructuring
40200000 USD
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
52000000 USD
CY2014 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3583100000 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
6864900000 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
7913200000 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
198800000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
28200000 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15400000 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111600000 USD
CY2014 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
375000000 USD
CY2015 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
850000000 USD
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1200000000 USD
CY2014 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
20500000 USD
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
13100000 USD
CY2016 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
38600000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
287800000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
643000000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
616100000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Prepaid Taxes
PrepaidTaxes
550600000 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
817000000 USD
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
54900000 USD
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
54200000 USD
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
43700000 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5930500000 USD
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2014 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2800000 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-61300000 USD
CY2016 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2800000 USD
CY2014 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2718900000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4063000000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7378900000 USD
CY2014 us-gaap Profit Loss
ProfitLoss
2941600000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
820200000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
924800000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
1019500000 USD
CY2015Q4 us-gaap Profit Loss
ProfitLoss
828700000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
3593200000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
969200000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
1048400000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
1030200000 USD
CY2016Q4 us-gaap Profit Loss
ProfitLoss
647900000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
3695700000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3517700000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3941100000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2187600000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2501800000 USD
CY2014 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-12700000 USD
CY2015 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-171000000 USD
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3400000 USD
CY2014 us-gaap Repayments Of Debt
RepaymentsOfDebt
2700000 USD
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
2100000 USD
CY2016 us-gaap Repayments Of Debt
RepaymentsOfDebt
2700000 USD
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1893400000 USD
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2012800000 USD
CY2016 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1973300000 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
93400000 USD
CY2016 us-gaap Restructuring Charges
RestructuringCharges
33100000 USD
CY2016 us-gaap Restructuring Costs
RestructuringCosts
10300000 USD
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
37300000 USD
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
5100000 USD
CY2016 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-2300000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12208400000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15071600000 USD
CY2014 us-gaap Revenues
Revenues
9703300000 USD
CY2015Q1 us-gaap Revenues
Revenues
2555000000 USD
CY2015Q2 us-gaap Revenues
Revenues
2591600000 USD
CY2015Q3 us-gaap Revenues
Revenues
2777900000 USD
CY2015Q4 us-gaap Revenues
Revenues
2839300000 USD
CY2015 us-gaap Revenues
Revenues
10763800000 USD
CY2016Q1 us-gaap Revenues
Revenues
2726800000 USD
CY2016Q2 us-gaap Revenues
Revenues
2894200000 USD
CY2016Q3 us-gaap Revenues
Revenues
2955800000 USD
CY2016Q4 us-gaap Revenues
Revenues
2872000000 USD
CY2016 us-gaap Revenues
Revenues
11448800000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8203400000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2172300000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2198600000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2391700000 USD
CY2015Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2425900000 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9188500000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2309400000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2466000000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2539600000 USD
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2502900000 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9817900000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2232300000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2113100000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1947900000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
155300000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
161400000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
154800000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
42700000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
38000000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10400000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15000000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
107000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
66000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.94
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
54.06
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
53.75
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.00
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y
CY2016 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
6200000 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
41000 shares
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140300000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
125100000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52100000 USD
CY2014 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
54900000 USD
CY2015 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
54200000 USD
CY2016 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
43700000 USD
CY2015Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000000 USD
CY2016Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000000 USD
CY2011Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
20000000 shares
CY2016Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1300000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
8620200000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10809000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
9372800000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
12140100000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8620800000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10814000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9374900000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12128600000 USD
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
208700000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
231900000 USD
CY2015 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2016 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
22600000 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
22600000 shares
CY2014 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2900000 shares
CY2015 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
16800000 shares
CY2016 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3300000 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2611700000 USD
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2611700000 USD
CY2014 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
886800000 USD
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000000 USD
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220800000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231200000 shares
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000000000 USD
CY2016Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
7600000000 USD
CY2014 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
72100000 USD
CY2015 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-1800000 USD
CY2016 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
49800000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
110100000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
131500000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
67900000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32400000 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
27000000 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
23400000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
49900000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
13300000 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
60500000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
42500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
64300000 USD
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4100000 USD
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3100000 USD
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
9100000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
20800000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
10500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
7200000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
86100000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
36300000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
12500000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
25200000 USD
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1600000 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1200000 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1400000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
53600000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
15700000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
26900000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
426200000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
483800000 USD
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
662700000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
605500000 USD
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
800000 shares
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
500000 shares
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237200000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235600000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235700000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232600000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219300000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219400000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219400000 shares
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217000000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218800000 shares
CY2014 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1000000 shares
CY2015 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
4600000 shares
CY2016 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
700000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
236400000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235000000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235300000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232200000 shares
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220400000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230700000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218900000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219100000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218900000 shares
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216600000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218400000 shares
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk include cash and cash equivalents, investments, derivatives and accounts receivable. We attempt to minimize the risks related to cash and cash equivalents and investments by investing in a broad and diverse range of financial instruments as previously defined by us. We have established guidelines related to credit ratings and maturities intended to safeguard principal balances and maintain liquidity. Our investment portfolio is maintained in accordance with our investment policy, which defines allowable investments, specifies credit quality standards and limits the credit exposure of any single issuer. We minimize credit risk resulting from derivative instruments by choosing only highly rated financial institutions as counterparties.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Concentrations of credit risk with respect to receivables, which are typically unsecured, are somewhat mitigated due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable arise from product sales in the U.S. and Europe and have standard payment terms which generally require payment within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30 to 90 days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We monitor the financial performance and creditworthiness of our customers so that we can properly assess and respond to changes in their credit profile. We continue to monitor these conditions and assess their possible impact on our business. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, two wholesale distributors individually accounted for approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.4%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.1%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, of accounts receivable, net, respectively. </font></div></div>
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name View Source Status
0000875045-17-000009-index-headers.html Edgar Link pending
0000875045-17-000009-index.html Edgar Link pending
0000875045-17-000009.txt Edgar Link pending
0000875045-17-000009-xbrl.zip Edgar Link pending
alprolixchart.jpg Edgar Link pending
amortizationchart.jpg Edgar Link pending
avonex.jpg Edgar Link pending
avonexchart.jpg Edgar Link pending
benepalia02.jpg Edgar Link pending
biib-20161231.xml Edgar Link completed
biib-20161231.xsd Edgar Link pending
biib-20161231x10k.htm Edgar Link pending
biib-20161231xex21.htm Edgar Link pending
biib-20161231xex23.htm Edgar Link pending
biib-20161231xex311.htm Edgar Link pending
biib-20161231xex312.htm Edgar Link pending
biib-20161231xex321.htm Edgar Link pending
biib-20161231_cal.xml Edgar Link unprocessable
biib-20161231_def.xml Edgar Link unprocessable
biib-20161231_lab.xml Edgar Link unprocessable
biib-20161231_pre.xml Edgar Link unprocessable
biogenlogostandarda06.jpg Edgar Link pending
biosimilarschart.jpg Edgar Link pending
collabprofitsharingchart.jpg Edgar Link pending
costofsaleschart.jpg Edgar Link pending
eloctatechart.jpg Edgar Link pending
equitinlossofinvesteechart.jpg Edgar Link pending
fampyra.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
financialhighlightschart.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
flixabi.jpg Edgar Link pending
fumaderm.jpg Edgar Link pending
gainlossfairvaluechart.jpg Edgar Link pending
gazyva.jpg Edgar Link pending
geographicsaleschart.jpg Edgar Link pending
incometaxchart.jpg Edgar Link pending
noncontrollinginterestchart.jpg Edgar Link pending
otherincomeexpensechart.jpg Edgar Link pending
otherrevenueschart.jpg Edgar Link pending
plegridy.jpg Edgar Link pending
principalproductschart.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
rdpiechart2014.jpg Edgar Link pending
rdpiechart2015.jpg Edgar Link pending
rdpiechart2016.jpg Edgar Link pending
report.css Edgar Link pending
researchanddevelopment.jpg Edgar Link pending
researchanddevelopmentchart.jpg Edgar Link pending
reserveschart.jpg Edgar Link pending
restructuringchargeschart.jpg Edgar Link pending
rituxan.jpg Edgar Link pending
sellinggeneraladminchart.jpg Edgar Link pending
Show.js Edgar Link pending
spinrazalogonewa01.jpg Edgar Link pending
stockperformancechart.jpg Edgar Link pending
tecfidera.jpg Edgar Link pending
tecfiderachart.jpg Edgar Link pending
teclitigationchart.jpg Edgar Link pending
tysabri.jpg Edgar Link pending
tysabrichart.jpg Edgar Link pending
unconsoljointbusinesschart.jpg Edgar Link pending
zinbryta.jpg Edgar Link pending
zinbrytachart.jpg Edgar Link pending